With the improvement of people's living standards and the enhancement of health awareness, medicinal and edible homologous products are gradually favored by the market. In order to better meet the needs of consumers, the 2024 China Medicine and Food Homologous Brand Booster Action was launched (2023-2025). This action aims to promote the healthy development of the medicine and food homology industry through the integration of high-quality resources, enhance brand awareness and reputation, and provide consumers with safer, healthier and better food choices.
1. Background and significance
The homology of medicine and food means that traditional Chinese medicine and food have the same efficacy and effect, which can complement each other and regulate various functions in the human body, which is of great significance for maintaining human health and preventing diseases. With the increasing attention to health and food safety, the market demand for medicinal and edible homologous products is also growing. However, at present, there are many homologous brands of medicine and food in the market, and the quality of products is uneven, and consumers have certain confusion and doubts when choosing. Therefore, the development of the joint Hui-China medicine and food homologous brand assistance action is of great practical significance and market demand.
2. Objectives
1.Enhance brand influence: Through this action, 100 characteristic brands of medicine and food homology will be selected across the country, the popularity and reputation of their brands will be enhanced, the brand image will be established, and consumers' trust in the brand will be enhanced.
2.Standardize the market order: Through this action, standardize the order of the medicine and food homologous market, and enhance the competitiveness and sustainable development of the entire industry.
3.Promote industrial upgrading: Through this action, we will promote the upgrading and development of China's medicine and food homology industry, improve the quality and efficiency of products, and provide consumers with safer, healthier and better food choices.
Third, the implementation plan
1.Resource integration: Integrate high-quality medicinal and edible homologous product resources, including Chinese herbal medicines, ingredients and processing, as well as channels, applications and other links, and establish a complete first-chain system to ensure product quality and safety.
2.Brand promotion: brand promotion through a variety of channels and methods, including online and offline publicity, cooperation, event planning and other mainstream and offline health chains, to improve brand awareness and reputation.
3.Market regulation: Formulate standards and specifications for Chinese medicine and food homologous products, establish a sound market supervision mechanism, standardize market order, and protect the legitimate rights and interests of consumers.
4.Industrial upgrading: Strengthen scientific and technological innovation and R&D efforts, promote the upgrading and development of China's medicine and food homology industry, and improve the added value and market competitiveness of products.
5.Win-win cooperation: Establish cooperative relations with upstream and downstream enterprises in the industrial chain to achieve resource sharing, complementary advantages, mutual benefit and win-win situation.
Expected results
1.Enhance consumer confidence: Through this action, enhance consumers' trust and confidence in the national medicine and food homologous characteristic products, and increase market share.
2.Promote the healthy development of the industry: standardize the order of the medicine and food homologous market, and promote the healthy development and sustainable development of the entire industry.
3.Industrial upgrading and innovation: Promote the upgrading and innovative development of the medicine and food homology industry, and improve the added value and market competitiveness of products.
4.Significant social benefits: Provide consumers with safer, healthier and better food choices, and promote the health and sustainable development of society.
5. Summary and outlook
The China Medicine and Food Homology Brand Empowerment Action (2023-2025) is an initiative of great significance to promote the healthy development of China's medicine and food industry, enhance brand awareness and reputation, and provide consumers with safer, healthier and better food choices. Through the implementation of this action, it will further standardize the market order, promote the healthy development of the industry, promote industrial upgrading and innovative development, and enhance consumer confidence and social benefits. Looking forward to the future, the Lianhui-China Medicine and Food Homology Brand Booster Action will continue to play an important role and make positive contributions to the sustainable development of the medicine and food homology industry.
Coming soon:
China's 100 medicine and food homologous characteristic brands help the action.
2024 The list of the first batch of medicine and food homology characteristic enterprises.
Stay tuned!